{
    "clinical_study": {
        "@rank": "84234", 
        "brief_summary": {
            "textblock": "The target groups in this study are brain waves and neurotransmitters (chemical messengers)\n      in the brain.  Subjects with diagnosed with schizophrenia will be studied.  The study will\n      help understand more about normal brain functioning and how that functioning differs in\n      people with schizophrenia.  Another purpose of this study is to determine how the altered\n      brain functioning in schizophrenia contributes the symptoms found in the illness."
        }, 
        "brief_title": "5HT3 Antagonism and Auditory Gating in Schizophrenia", 
        "completion_date": "June 2003", 
        "condition": "Schizophrenia", 
        "condition_browse": {
            "mesh_term": "Schizophrenia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Subjects with diagnosed with schizophrenia will be studied."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "July 3, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00018850", 
            "org_study_id": "MHBS-013-99F"
        }, 
        "intervention": [
            {
                "intervention_name": "ondansetron", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "neuropsychological testing", 
                "intervention_type": "Behavioral"
            }, 
            {
                "intervention_name": "nicotine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "haloperidol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Haloperidol", 
                "Ondansetron", 
                "Haloperidol decanoate", 
                "Nicotine", 
                "Nicotine polacrilex"
            ]
        }, 
        "keyword": [
            "schizophrenia", 
            "ondansetron", 
            "nicotine", 
            "haloperidol"
        ], 
        "lastchanged_date": "January 20, 2009", 
        "location": {
            "facility": {
                "address": {
                    "city": "Denver", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80013"
                }, 
                "name": "VAMC"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "5HT3 Antagonism and Auditory Gating in Schizophrenia", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00018850"
        }, 
        "source": "Department of Veterans Affairs", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "June 1998", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2004"
    }, 
    "geocoordinates": {
        "VAMC": "39.739 -104.985"
    }
}